Literature DB >> 30610091

Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments.

Julia R Dahlqvist1, Sofie T Oestergaard2, Nanna S Poulsen2, Carsten Thomsen2, John Vissing2.   

Abstract

OBJECTIVE: To investigate the phenotypic features, with emphasis on muscle, in 40 patients with spinobulbar muscular atrophy (SBMA) using quantitative MRI, stationary dynamometry, questionnaires, and functional tests.
METHODS: Patients with genetically confirmed SBMA were included. MRI was used to describe muscle involvement and quantify muscle fat fractions of arm, back, and leg muscles. Muscle strength was assessed with a stationary dynamometer. All patients were evaluated with the SBMA functional rating scale and the 6-minute walk test among others. MRI and muscle strength results were compared with healthy controls.
RESULTS: Forty patients with SBMA were included. The muscle fat content was significantly higher in patients with SBMA than in controls: paraspinal fat fraction was 45% vs 33% in controls, thigh fat fraction 36% vs 14%, calf fat fraction 37% vs 15%, upper arm fat fraction 20% vs 8%, and forearm fat fraction was 20% vs 9%. Muscle strength in patients was reduced to approximately half of that in controls in all muscles. Muscle fat content correlated with muscle strength, SBMA functional rating scale score, and 6-minute walk test distance.
CONCLUSIONS: Our results show that there is a diffuse muscle involvement pattern in SBMA. Leg muscles are more vulnerable than arm muscles, especially the posterior flexor muscles. The muscle fat content correlates with muscle function and disease severity.
© 2019 American Academy of Neurology.

Entities:  

Mesh:

Year:  2019        PMID: 30610091     DOI: 10.1212/WNL.0000000000006887

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Characteristic muscle signatures assessed by quantitative MRI in patients with Bethlem myopathy.

Authors:  Ruth Salim; Julia Rebecka Dahlqvist; Tahmina Khawajazada; Konni Kass; Karoline Lolk Revsbech; Josefine de Stricker Borch; Aisha Munawar Sheikh; John Vissing
Journal:  J Neurol       Date:  2020-05-03       Impact factor: 4.849

2.  Muscle contractility in spinobulbar muscular atrophy.

Authors:  Julia R Dahlqvist; Sofie T Oestergaard; Nanna S Poulsen; Kirsten Lykke Knak; Carsten Thomsen; John Vissing
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

3.  The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.

Authors:  Pierre-François Pradat; Emilien Bernard; Philippe Corcia; Philippe Couratier; Christel Jublanc; Giorgia Querin; Capucine Morélot Panzini; François Salachas; Christophe Vial; Karim Wahbi; Peter Bede; Claude Desnuelle
Journal:  Orphanet J Rare Dis       Date:  2020-04-10       Impact factor: 4.123

4.  Patients With Becker Muscular Dystrophy Have Severe Paraspinal Muscle Involvement.

Authors:  Aisha M Sheikh; Karen Rudolf; Josefine de Stricker Borch; Tahmina Khawajazada; Nanna Witting; John Vissing
Journal:  Front Neurol       Date:  2021-05-21       Impact factor: 4.003

Review 5.  Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatment.

Authors:  Christopher Grunseich; Kenneth H Fischbeck
Journal:  Curr Opin Neurol       Date:  2020-10       Impact factor: 6.283

6.  Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4.

Authors:  Christopher Grunseich; Aneesh Patankar; Joshua Amaya; Jason A Watts; Dongjun Li; Prisila Ramirez; Alice B Schindler; Kenneth H Fischbeck; Vivian G Cheung
Journal:  Ann Neurol       Date:  2020-01-28       Impact factor: 10.422

Review 7.  Metabolic Dysfunction in Spinal Muscular Atrophy.

Authors:  Marc-Olivier Deguise; Lucia Chehade; Rashmi Kothary
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.